CF
NVO

Centaurus Financial’s Novo Nordisk NVO Stock Holding History

Centaurus Financial’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.41M Sell
38,244
-1,503
-4% -$71.2K 0.07% 265
2025
Q4 		$2.02M Buy
39,747
+13,181
+50% +$674K 0.09% 200
2025
Q3 		$1.47M Buy
26,566
+15,467
+139% +$905K 0.07% 248
2025
Q2 		$766K Buy
11,099
+950
+9% +$64.6K 0.04% 356
2025
Q1 		$705K Buy
10,149
+794
+8% +$65.6K 0.04% 359
2024
Q4 		$805K Sell
9,355
-1,629
-15% -$176K 0.05% 309
2024
Q3 		$1.31M Buy
10,984
+3,809
+53% +$508K 0.08% 224
2024
Q2 		$1.02M Buy
7,175
+3,560
+98% +$472K 0.07% 238
2024
Q1 		$464K Buy
+3,615
New +$430K 0.03% 401
2023
Q2 		– Sell
-5,936
Closed -$472K – 871
2023
Q1 		$472K Buy
5,936
+1,980
+50% +$140K 0.04% 413
2022
Q4 		$268K Buy
+3,956
New +$232K 0.03% 522
2018
Q3 		– Sell
-1,156
Closed -$27K – 1533
2018
Q2 		$27K Buy
+1,156
New +$27.5K ﹤0.01% 1152

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Centaurus Financial's NVO Position: Q1 2026 in Review

Centaurus Financial reduced its Novo Nordisk (NVO) stake by 3.8% in Q1 2026, selling an estimated $71.2K and leaving 38,244 shares worth $1.41M. The position accounts for 0.07% of the portfolio, ranked #265.

Centaurus Financial first reported a position in NVO in Q2 2018 and has held it in 12 quarters since. The position peaked at $2.02M in Q4 2025. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Centaurus Financial held 38,244 shares of Novo Nordisk worth $1.41M as of Q1 2026.
  • Centaurus Financial sold 1,503 Novo Nordisk shares in Q1 2026, an estimated $71.2K.
  • Novo Nordisk made up 0.07% of Centaurus Financial's portfolio in Q1 2026, its #265 holding.
  • Centaurus Financial first reported a position in Novo Nordisk in Q2 2018 and has held it in 12 quarters since.
  • Centaurus Financial's Novo Nordisk position peaked at $2.02M in Q4 2025.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Centaurus Financial's 13F filing for Q1 2026, filed 18 May 2026.